. -- merger failure ; innovation performance ; technology ; open innovation ; biotechnology …This paper addresses the key determinants of merger failure, in particular the role of innovation (post …-merger performance) and technology (ex-ante selection) when firms decide to separate. After a brief review of the existing literature we …

This paper addresses the key determinants of merger failure, in par- ticular the role of innovation (post …-merger performance) and technology (ex-ante selection) when rms decide to separate. After a brief review of the existing literature we … introduce a model of process innovation where merged firms exibit intra-merger spillover of knowledge under different mar- ket …

This paper addresses the key determinants of merger failure, in particularthe role of innovation (post …-merger performance) and technology (ex-anteselection) when firms decide to separate. After a brief review of the existingliterature we … introduce a model of process innovation where merged firmsexibit intra-merger spillover of knowledge under different market …

Indian pharmaceutical industry from a mere importer and distributor of drugs and pharmaceuticals to an innovation-driven cost …

Indian pharmaceutical industry from a mere importer and distributor of drugs and pharmaceuticals to an innovation-driven cost …

innovation success on organizational performance using path analysis. The obtained results indicated direct positive and …

-based companies, and planning technology and innovation policies … of patents can be taken into account. Our data covers biotechnology patents held by Finnish biotechnology companies …

shares. We investigate how pharmaceutical firms use mergers and acquisitions to boost their innovation performance which has … successful in their innovation endeavours than firms with other goal orientation. Further, the firms’ prior acquisition … experience appears to aid their innovation performance. However, we found that target size can affect the post …

biotechnology industry in Italy, whose firms, by definition, have Intellectual Property (IP) activities in their portfolios. For …

factors of success in drug development programs at different stages of innovation process. We use economies of scale, scope, R … a project differs in relation to the discovery and development stages of innovation, respectively. Our main finding is … discovery stage of innovation, while in the later development stage, the effects of competition outweigh any benefits from …